Title:
【発明の名称】タンパク質
Document Type and Number:
Japanese Patent JP2002528112
Kind Code:
A
Abstract:
A protein is described which is capable of binding to alpha2 macro globulin. The protein comprises the amino acid sequence of SEQ ID No: 1 or a functional variant thereof. The invention also relates to a peptide comprising a fragment of the protein of at least six amino acids in length. A protein or peptide which is capable of generating a protective immune response to Group A streptococcus comprises the amino acid sequence of SEQ ID No: 1, a functional variant thereof or a functional variant of at least six amino acids in length of either thereof. Such a protein or peptide may be used in a vaccine composition together with a pharmaceutically acceptable carrier.
Inventors:
Björk, Lars, Henrik
Rasmussen, Magnus
Rasmussen, Magnus
Application Number:
JP2000579627A
Publication Date:
September 03, 2002
Filing Date:
November 02, 1999
Export Citation:
Assignee:
Actinova limited
International Classes:
C12N15/09; A61K39/09; A61K39/395; A61P31/04; C07K14/315; C07K16/12; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02; A61K39/00; (IPC1-7): C12N15/09; A61K39/09; A61K39/395; A61P31/04; C07K14/315; C07K16/12; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02
Attorney, Agent or Firm:
Akira Asamura (3 outside)